Primidone Tablet
Product Images NDC 42291-511

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Primidone (NDC 42291-511). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

509 01

FDA Label Image

511 01

This is a description of Primidone tablets, USP, an anticonvulsant medication. Each tablet contains 250mg of the active ingredient, Primidone, and is dispensed with a child-resistant closure. The recommended dosage is not specified in the included text. It is advised to store the medication at controlled room temperature and keep it out of reach of children. The medication is manufactured by AKEFE, Pubsi T JB4TE and Amneal Pharmaceuticals of N LLC, Bookhaven, N 11710. NDC 42291-511-01 is also included in the text.*

FDA Label Image

Dosage

FDA Label Image

Primidone Tablets Usp 1

This text seems to be a chemical formula or a description of a chemical compound. It mentions a molecule named "CoHNO" with a molecular weight of 218.25. It is not possible to provide more information without additional context about the purpose or application of this molecule.*

FDA Label Image

Table 1

Table 1 provides an analysis of the risk associated with antiepileptic drugs by indication. The table presents data on the number of events per 1000 patients for those on placebo and those on the drug for three different indications: epilepsy, psychiatric, and other. The relative risk and risk difference are also included in the table.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.